z-logo
open-access-imgOpen Access
Repetitive hyperpnoea causes peripheral airway obstruction and eosinophilia
Author(s) -
Davis M.S.,
Freed A.N.
Publication year - 1999
Publication title -
european respiratory journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.021
H-Index - 241
eISSN - 1399-3003
pISSN - 0903-1936
DOI - 10.1034/j.1399-3003.1999.14a11.x
Subject(s) - medicine , airway , peripheral , bronchoscopy , bronchoalveolar lavage , airway resistance , asthma , eosinophilia , airway obstruction , inflammation , anesthesia , lung , immunology
Hyperpnoea of canine peripheral airways with dry air results in airway obstruction, mucosal damage, and inflammation. The purpose of this study was to evaluate the effect of repeated dry air challenge (DAC) on airway obstruction, reactivity and the development of airway inflammation in dogs. Canine peripheral airways received DAC (delivered under general anaesthesia through a bronchoscope) every 48 h for two weeks. Peripheral airway resistance and reactivity were measured prior to each DAC. After the final DAC, bronchoalveolar lavage fluid (BALF) cells and soluble mediators from challenged and control airways were measured. Repeated bronchoscopy had no effect on airway mechanics. Repeated DAC produced cumulative increases in peripheral airway resistance and peak obstructive response to DAC. The response to hypocapnia was also increased in airways receiving repeated DAC. However, when the response to agonists was expressed as a change from baseline, consistent significant increases were not observed. Repeated bronchoscopy produced insignificant changes in BALF cells and eicosanoid mediators. Repeated DAC produced marked eosinophilic inflammation and increased prostaglandins D 2 , E 2 , and F 2α , as well as leukotrienes C 4 –E 4 . In conclusion, repeated dry air challenge in dogs in vivo causes persistent airway obstruction and inflammation not unlike that found in human asthma. Eur Respir J 1999; 14: 57–62.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here